Page last updated: 2024-10-25

ciprofloxacin and Basal Ganglia Diseases

ciprofloxacin has been researched along with Basal Ganglia Diseases in 1 studies

Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.

Basal Ganglia Diseases: Diseases of the BASAL GANGLIA including the PUTAMEN; GLOBUS PALLIDUS; claustrum; AMYGDALA; and CAUDATE NUCLEUS. DYSKINESIAS (most notably involuntary movements and alterations of the rate of movement) represent the primary clinical manifestations of these disorders. Common etiologies include CEREBROVASCULAR DISORDERS; NEURODEGENERATIVE DISEASES; and CRANIOCEREBRAL TRAUMA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Singh, J1
Agarwal, AK1
Sudrania, SP1

Other Studies

1 other study available for ciprofloxacin and Basal Ganglia Diseases

ArticleYear
Extrapyramidal syndrome following ciprofloxacin treatment.
    Indian pediatrics, 1994, Volume: 31, Issue:5

    Topics: Basal Ganglia Diseases; Child, Preschool; Ciprofloxacin; Humans; Male

1994